StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
3985
This month
7
This year
1432
Publishing Date
2023 - 10 - 27
15
2023 - 07 - 28
10
2023 - 05 - 17
10
2023 - 05 - 04
11
2023 - 05 - 03
92
2023 - 05 - 02
74
2023 - 05 - 01
92
2023 - 04 - 28
21
2023 - 04 - 27
15
2023 - 03 - 13
18
2023 - 02 - 23
12
2023 - 01 - 25
10
2023 - 01 - 09
14
2022 - 10 - 14
11
2022 - 10 - 06
10
2022 - 09 - 26
10
2022 - 09 - 15
10
2022 - 09 - 05
10
2022 - 08 - 03
11
2022 - 07 - 28
10
2022 - 07 - 12
10
2022 - 05 - 17
9
2022 - 05 - 09
10
2022 - 03 - 29
9
2022 - 03 - 16
11
2022 - 03 - 01
9
2022 - 02 - 18
10
2022 - 01 - 07
11
2021 - 12 - 14
9
2021 - 11 - 22
9
2021 - 11 - 08
9
2021 - 10 - 28
9
2021 - 10 - 26
9
2021 - 09 - 08
10
2021 - 08 - 31
9
2021 - 08 - 30
9
2021 - 08 - 05
13
2021 - 07 - 29
13
2021 - 07 - 01
12
2021 - 06 - 28
13
2021 - 06 - 25
11
2021 - 06 - 21
9
2021 - 06 - 09
11
2021 - 06 - 01
11
2021 - 05 - 24
9
2021 - 05 - 20
9
2021 - 05 - 19
9
2021 - 05 - 17
9
2021 - 05 - 11
9
2021 - 05 - 10
14
2021 - 05 - 06
11
2021 - 05 - 03
11
2021 - 04 - 29
11
2021 - 04 - 26
11
2021 - 04 - 23
9
2021 - 04 - 14
9
2021 - 04 - 13
12
2021 - 04 - 09
11
2021 - 04 - 07
9
2021 - 03 - 18
11
Sector
Commercial services
39
Communications
47
Construction
1
Consumer durables
20
Consumer non-durables
53
Consumer services
7
Distribution services
8
Educational services
1
Electronic technology
25
Energy minerals
8
Finance
84
Finance and insurance
10
Health care and social assistance
5
Health services
26
Health technology
3985
Industrial services
2
Information
2
Manufacturing
268
Mining, quarrying, and oil and gas extraction
1
Miscellaneous
8
N/a
209
Non-energy minerals
2
Process industries
24
Producer manufacturing
17
Professional, scientific, and technical services
28
Retail trade
11
Technology services
38
Transportation
2
Utilities
1
Wholesale trade
6
Tags
Acquisition
87
Alliances
85
America
48
Antibody
57
Approval
86
Biopharma
66
Biotech
86
Biotechnology
96
Business
68
Cancer
180
Children
63
Clinical-trials-phase-ii
47
Clinical-trials-phase-iii
77
Collaboration
91
Companies
53
Conference
48
Covid
128
Covid-19
110
Deal
48
Diabetes
56
Disease
162
Drug
210
Dupixent
106
Earnings
88
Europe
87
Events
51
Fda
177
Financial
135
Financial results
72
Genetown
66
Global
282
Growing
50
Growth
274
Health
63
Insulin
50
Iot
55
Market
575
Money
64
N/a
2478
News
105
People
211
Pharm-country
53
Pharma
172
Pharmaceutical
119
Phase 3
44
Positive
96
Potential
54
Report
243
Research
234
Results
335
Sanofi
160
Spac
62
Study
71
Technology
65
Therapeutics
282
Therapy
102
Treatment
231
Trial
148
Update
79
Vaccine
250
Entities
3m company
868
Abb ltd
1301
Abbott laboratories
1543
Abbvie inc.
908
Accenture plc
540
Alphabet inc.
1101
Amgen inc.
694
Apple inc.
1091
Arcelormittal
500
Arrival
3798
Astrazeneca plc
587
Athena consumer acquisition corp.
523
Becton, dickinson and company
722
Bnp paribas
1628
Boston scientific corporation
524
Bristol-myers squibb company
596
Broadcom inc.
521
Cisco systems, inc.
808
Danaher corporation
724
Dell technologies inc.
516
Dow inc.
521
Eli lilly and company
1546
Ericsson
1459
Extreme networks, inc.
581
First bank
557
Ford motor company
564
Gartner, inc.
523
General electric company
851
Glaxosmithkline plc
825
Honeywell international inc.
1612
Hubspot, inc.
1290
Intel corporation
874
International business machines corporation
604
Johnson & johnson
3972
Kering
1005
Koninklijke philips n.v.
884
Lithium corp
869
Live nation entertainment, inc.
717
Lockheed martin corporation
519
Medtronic plc
1192
Microsoft corporation
1126
Morgan stanley
3637
Nokia corp
884
Nokia corporation
824
Northrop grumman corporation
532
Novartis ag
1108
Novo nordisk a/s
566
Oracle corporation
1080
Orange
6070
Panasonic corp
590
Pfizer, inc.
642
Sanofi
3985
Sap se
1377
Snowflake inc.
705
Teva pharmaceutical industries ltd
564
Thermo fisher scientific inc
1427
Total se
1577
Verizon communications inc.
1056
Vision sensing acquisition corp.
498
X financial
562
Symbols
ABBV
175
ABT
171
ADCT
19
ALNY
73
ALPMF
52
ALPMY
52
ALXN
24
AMGN
144
AVEO
20
AZN
182
AZNCF
142
BAX
41
BDX
32
BHC
28
BIIB
41
BMRN
26
BMY
106
BNTX
163
BPMC
20
BSX
24
BY
26
CLVS
20
CMXHF
19
CSLLY
19
DNLI
18
ENDP
19
EPZM
19
FNCTF
45
GILD
57
GLAXF
239
GSK
303
IGMS
30
INCY
106
IPHA
93
IPHYF
66
JNJ
423
KPTI
25
KYMR
24
LGND
20
LLY
290
MDT
42
MOBV
65
MRNA
31
MYL
37
NVO
132
NVS
286
NVSEF
241
PFE
152
PRGO
58
PRVB
285
RCFA
83
REGN
231
SNY
3985
SNYNF
3040
TAK
53
TBIO
22
TEVJF
198
TMO
33
VIR
22
VTRS
75
Exchanges
Amex
18
Lse
91
Nasdaq
3985
Nyse
1388
Tsx
8
Crawled Date
2023 - 10 - 27
15
2023 - 08 - 10
10
2023 - 07 - 28
10
2023 - 05 - 04
12
2023 - 05 - 03
93
2023 - 05 - 02
75
2023 - 05 - 01
92
2023 - 04 - 28
25
2023 - 04 - 27
11
2023 - 03 - 13
18
2023 - 02 - 23
13
2023 - 01 - 25
10
2023 - 01 - 09
13
2022 - 10 - 14
11
2022 - 09 - 26
10
2022 - 09 - 15
10
2022 - 09 - 05
11
2022 - 08 - 03
11
2022 - 07 - 28
10
2022 - 07 - 12
10
2022 - 05 - 17
9
2022 - 05 - 09
10
2022 - 03 - 29
9
2022 - 03 - 16
11
2022 - 03 - 01
9
2022 - 02 - 23
9
2022 - 02 - 18
10
2022 - 01 - 07
11
2021 - 11 - 22
9
2021 - 11 - 08
9
2021 - 10 - 28
9
2021 - 10 - 26
9
2021 - 09 - 08
10
2021 - 08 - 31
9
2021 - 08 - 30
9
2021 - 08 - 06
9
2021 - 08 - 05
12
2021 - 07 - 29
13
2021 - 07 - 13
9
2021 - 07 - 01
12
2021 - 06 - 28
13
2021 - 06 - 25
11
2021 - 06 - 09
12
2021 - 06 - 01
11
2021 - 05 - 20
9
2021 - 05 - 19
9
2021 - 05 - 17
9
2021 - 05 - 11
9
2021 - 05 - 10
14
2021 - 05 - 06
11
2021 - 05 - 03
11
2021 - 04 - 29
11
2021 - 04 - 26
11
2021 - 04 - 23
9
2021 - 04 - 14
9
2021 - 04 - 13
13
2021 - 04 - 09
11
2021 - 04 - 07
9
2021 - 03 - 31
9
2021 - 03 - 18
11
Crawled Time
00:00
84
00:01
1
00:20
19
01:00
74
01:10
1
02:00
38
03:00
29
04:00
24
04:20
6
05:00
59
06:00
140
06:01
5
06:03
2
07:00
128
08:00
102
08:11
2
08:20
6
09:00
91
09:52
1
10:00
98
10:10
1
10:41
1
10:51
1
11:00
250
11:36
1
11:49
1
12:00
310
12:01
1
12:15
27
12:20
72
12:30
31
12:34
1
12:53
1
13:00
242
13:15
30
13:20
59
13:30
42
14:00
235
14:15
31
14:20
48
14:30
30
15:00
177
15:15
20
15:20
50
15:30
39
16:00
215
16:20
25
17:00
194
17:01
2
18:00
175
18:11
2
18:31
2
19:00
141
20:00
136
20:20
15
21:00
174
22:00
136
22:12
2
22:14
5
23:00
101
Source
contravir.com
1
investors.biomarin.com
10
investors.phiopharma.com
1
ir.biolinerx.com
1
ir.stockpr.com
2
ir.voyagertherapeutics.com
2
ir.vtvtherapeutics.com
1
nutriband.com
1
purple-biotech.com
1
spacfeed.com
279
thehackettgroup.com
1
verupharma.com
1
www.agtc.com
1
www.algernonpharmaceuticals.com
2
www.alnylam.com
1
www.baldwinriskpartners.com
1
www.biospace.com
1499
www.capgemini.com
1
www.clarivate.com
6
www.crinetics.com
1
www.curevac.com
2
www.everbridge.com
1
www.fda.gov
42
www.globenewswire.com
669
www.inovio.com
3
www.interpublic.com
2
www.invobioscience.com
1
www.jupiterwellnessinc.com
2
www.kymeratx.com
1
www.modeln.com
46
www.nurixtx.com
1
www.oncocyte.com
1
www.precisionbiosciences.com
2
www.preludetx.com
1
www.prnewswire.com
1392
www.snowflake.com
1
www.sunopta.com
1
www.sutrobio.com
1
www.vbivaccines.com
1
www.veeva.com
2
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
entities :
Sanofi
save search
The Rockefeller Foundation Commits USD 100 Million to Test and Scale Climate and Health Solutions Globally
Published:
2023-12-02
(Crawled : 12:20)
- prnewswire.com
SNY
|
$46.72
-0.06%
-0.06%
1.1M
|
Health Technology
|
Email alert
Add to watchlist
SNYNF
|
$94.0
1.34%
1.34%
860
|
Health Technology
|
Email alert
Add to watchlist
test
health
solutions
100
41 Funders, Partners Endorse New Guiding Principles for Financing Climate and Health Solutions to Protect Health
Published:
2023-12-02
(Crawled : 12:20)
- prnewswire.com
SNY
|
$46.72
-0.06%
-0.06%
1.1M
|
Health Technology
|
Email alert
Add to watchlist
SNYNF
|
$94.0
1.34%
1.34%
860
|
Health Technology
|
Email alert
Add to watchlist
health
solutions
Laryngeal Cancer Therapeutics Market size to grow by USD 575.25 million from 2022-2027| Accord Healthcare Ltd., Amgen Inc., AstraZeneca Plc, Athenex Inc. and more among the major companies in the market- Technavio
Published:
2023-12-01
(Crawled : 23:00)
- prnewswire.com
SNY
|
$46.72
-0.06%
-0.06%
1.1M
|
Health Technology
|
Email alert
Add to watchlist
TEVJF
|
$8.5
5.21%
100
|
Health Technology
|
Email alert
Add to watchlist
SNYNF
|
$94.0
1.34%
1.34%
860
|
Health Technology
|
Email alert
Add to watchlist
AZN
|
$64.79
0.31%
0.03%
3.6M
|
Health Technology
|
Email alert
Add to watchlist
AZNCF
|
$125.0
-2.72%
8.8%
3.4K
|
Health Technology
|
Email alert
Add to watchlist
AMGN
G
|
$272.45
1.04%
0.0%
2.3M
|
Health Technology
|
Email alert
Add to watchlist
companies
astrazeneca
cancer
therapeutics
market
Neuromuscular Disease Therapeutics Market size to grow by USD 65.13 billion from 2022-2027| Aquestive Therapeutics Inc., Bausch Health Companies Inc., Biogen Inc. and more among the major companies in the market- Technavio
Published:
2023-12-01
(Crawled : 19:00)
- prnewswire.com
SNYNF
|
$94.0
1.34%
1.34%
860
|
Health Technology
|
Email alert
Add to watchlist
NVSEF
|
$97.95
1.48%
2.98%
100
|
Health Technology
|
Email alert
Add to watchlist
BHC
|
$7.36
3.08%
0.0%
1.8M
|
Health Technology
|
Email alert
Add to watchlist
BIIB
|
$234.64
0.24%
0.26%
570K
|
Health Technology
|
Email alert
Add to watchlist
SNY
|
$46.72
-0.06%
-0.06%
1.1M
|
Health Technology
|
Email alert
Add to watchlist
BCLI
|
$0.26
-6.81%
-7.31%
3.7M
|
Health Technology
|
Email alert
Add to watchlist
VTRS
|
$9.37
2.07%
1.92%
6.4M
|
Health Technology
|
Email alert
Add to watchlist
NVS
|
$98.13
0.24%
-0.16%
1.2M
|
Health Technology
|
Email alert
Add to watchlist
disease
companies
health
therapeutics
market
GSK Pulls Ahead of Pfizer in RSV Vaccine Market as Arexvy Nears Blockbuster S...
Published:
2023-12-01
(Crawled : 14:30)
- biospace.com/
SNY
|
$46.72
-0.06%
-0.06%
1.1M
|
Health Technology
|
0.93%
|
O:
0.93%
H:
0.0%
C:
0.0%
vaccine
rsv
market
GSK Pulls Ahead of Pfizer in RSV Vaccine Market as Arexvy Nears Blockbuster Status
Published:
2023-12-01
(Crawled : 13:30)
- biospace.com/
SNY
|
$46.72
-0.06%
-0.06%
1.1M
|
Health Technology
|
0.93%
|
O:
0.93%
H:
0.0%
C:
0.0%
vaccine
rsv
market
Innovent Presents Clinical Data Update of IBI351 (KRAS G12C Inhibitor) Monotherapy in Lung Cancer and Colorectal Cancer at ESMO Asia Congress 2023
Published:
2023-12-01
(Crawled : 06:00)
- biospace.com/
SNY
|
$46.72
-0.06%
-0.06%
1.1M
|
Health Technology
|
0.93%
|
O:
0.93%
H:
0.0%
C:
0.0%
INCY
|
$54.02
-0.59%
1.07%
1.9M
|
Health Technology
|
-0.17%
|
O:
-0.17%
H:
0.0%
C:
0.0%
ibi351
lung
congress
update
cancer
asia
Teva Completes Closing of Exclusive Collaboration Deal to Deliver Inflammatory Bowel Disease Treatment
Published:
2023-11-30
(Crawled : 15:00)
- biospace.com/
SNYNF
|
$94.0
1.34%
1.34%
860
|
Health Technology
|
-0.35%
|
O:
-0.35%
H:
0.0%
C:
0.0%
TEVA
|
$9.71
-1.12%
0.0%
6.6M
|
Health Technology
|
1.34%
|
O:
-0.52%
H:
3.73%
C:
1.87%
SNY
|
$46.72
-0.06%
-0.06%
1.1M
|
Health Technology
|
-0.17%
|
O:
-1.09%
H:
0.0%
C:
0.0%
disease
treatment
collaboration
teva
deal
Metastatic HER2-Positive Breast Cancer Market to Grow by 2032 at a 5.2% CAGR | DelveInsight
Published:
2023-11-29
(Crawled : 22:00)
- prnewswire.com
SNYNF
|
$94.0
1.34%
1.34%
860
|
Health Technology
|
-0.35%
|
O:
-0.35%
H:
0.0%
C:
0.0%
SNY
|
$46.72
-0.06%
-0.06%
1.1M
|
Health Technology
|
-0.17%
|
O:
-1.09%
H:
0.0%
C:
0.0%
IMMP
|
$1.99
1.01%
83K
|
Health Technology
|
6.99%
|
O:
6.45%
H:
1.52%
C:
0.51%
breast
cancer
market
Deals, Dupixent and GLP-1 drug shortages
Published:
2023-11-29
(Crawled : 15:30)
- biospace.com/
SNY
|
$46.72
-0.06%
-0.06%
1.1M
|
Health Technology
|
-0.98%
|
O:
-0.15%
H:
0.07%
C:
-0.66%
drug
dupixent
Metastatic Non-small Cell Lung Cancer Market Forecast Analysis and with Focus on its Immune/Molecular Biomarker Types: PD-L1, EGFR, KRAS, ALK, BRAF, MET, ROS-1, HER2, RET fusion, and NTRK1/2/3 Gene fusion | DelveInsight
Published:
2023-11-28
(Crawled : 22:00)
- prnewswire.com
JNJ
|
$158.38
2.41%
0.0%
10M
|
Health Technology
|
3.36%
|
O:
-0.04%
H:
0.0%
C:
0.0%
LLY
2 d
|
$584.04
-1.18%
0.34%
3.6M
|
Health Technology
|
0.37%
|
O:
-0.06%
H:
0.0%
C:
0.0%
SNY
|
$46.72
-0.06%
-0.06%
1.1M
|
Health Technology
|
-0.98%
|
O:
-0.15%
H:
0.07%
C:
-0.66%
BPMC
|
$72.05
3.46%
0.0%
820K
|
Health Technology
|
1.86%
|
O:
0.5%
H:
1.86%
C:
-0.33%
lung
biomarker
cancer
cell
market
FDA Decisions: First Treatment for Desmoid Tumors and a Dry Eye Rejection for Aldeyra
Published:
2023-11-28
(Crawled : 15:00)
- biospace.com/
SNYNF
|
$94.0
1.34%
1.34%
860
|
Health Technology
|
-2.21%
|
O:
-1.89%
H:
0.02%
C:
0.02%
PRGO
P
|
$30.9
1.44%
0.0%
1.3M
|
Health Technology
|
-1.33%
|
O:
0.78%
H:
0.81%
C:
-1.71%
JNJ
|
$158.38
2.41%
0.0%
10M
|
Health Technology
|
3.44%
|
O:
0.09%
H:
0.0%
C:
0.0%
ABT
|
$104.88
0.57%
-0.01%
4.7M
|
Health Technology
|
1.47%
|
O:
-0.24%
H:
0.03%
C:
-0.39%
SNY
|
$46.72
-0.06%
-0.06%
1.1M
|
Health Technology
|
-2.37%
|
O:
-1.41%
H:
0.87%
C:
0.0%
fda
tumors
treatment
eye
Vaxcyte Appoints Jacks Lee to Board of Directors
Published:
2023-11-28
(Crawled : 14:00)
- globenewswire.com
PPRUF
|
$426.544
-2.5%
44.35%
1.5K
|
Consumer Non-Durables
|
-4.3%
|
O:
-1.83%
H:
1.83%
C:
-2.33%
SNYNF
|
$94.0
1.34%
1.34%
860
|
Health Technology
|
-2.21%
|
O:
-1.89%
H:
0.02%
C:
0.02%
PCVX
S
|
$53.81
3.94%
0.0%
600K
|
Health Technology
|
3.27%
|
O:
-1.82%
H:
1.91%
C:
1.75%
STRO
|
$2.75
5.36%
5.26%
1M
|
Health Technology
|
1.32%
|
O:
6.14%
H:
1.24%
C:
-5.79%
GTHX
|
$2.0
6.38%
5.53%
1.1M
|
Health Technology
|
12.2%
|
O:
-1.83%
H:
0.0%
C:
0.0%
SNY
|
$46.72
-0.06%
-0.06%
1.1M
|
Health Technology
|
-2.37%
|
O:
-1.41%
H:
0.87%
C:
0.0%
Insomnia Therapeutics Market to grow by USD 1 billion from 2022-2027 | North America to account for 60% of market growth - Technavio
Published:
2023-11-27
(Crawled : 22:00)
- prnewswire.com
SNYNF
|
$94.0
1.34%
1.34%
860
|
Health Technology
|
-2.21%
|
O:
-1.89%
H:
0.02%
C:
0.02%
VTRS
|
$9.37
2.07%
1.92%
6.4M
|
Health Technology
|
-2.56%
|
O:
-0.64%
H:
0.21%
C:
-1.93%
TAK
|
$14.17
0.14%
0.0%
830K
|
Health Technology
|
0.57%
|
O:
-0.07%
H:
0.28%
C:
0.21%
ABT
|
$104.88
0.57%
-0.01%
4.7M
|
Health Technology
|
1.47%
|
O:
-0.24%
H:
0.03%
C:
-0.39%
VNDA
|
$3.9
4.84%
4.86%
890K
|
Health Technology
|
4.49%
|
O:
2.81%
H:
0.0%
C:
-3.01%
SNY
|
$46.72
-0.06%
-0.06%
1.1M
|
Health Technology
|
-2.37%
|
O:
-1.41%
H:
0.87%
C:
0.0%
america
therapeutics
growth
market
Regeneron and Sanofi Find Further Positive Results for Dupixent in COPD
Published:
2023-11-27
(Crawled : 17:00)
- biospace.com/
SNY
|
$46.72
-0.06%
-0.06%
1.1M
|
Health Technology
|
-1.25%
|
O:
1.04%
H:
0.17%
C:
0.11%
dupixent
positive
copd
results
sanofi
Innate Pharma to Host Virtual KOL Event on Lacutamab
Published:
2023-11-27
(Crawled : 11:00)
- biospace.com/
SNY
|
$46.72
-0.06%
-0.06%
1.1M
|
Health Technology
|
-1.25%
|
O:
1.04%
H:
0.17%
C:
0.11%
IPHA
|
$2.44
1.67%
-2.13%
12K
|
Health Technology
|
-0.83%
|
O:
2.07%
H:
1.21%
C:
1.21%
pharma
Dupixent® (dupilumab) Significantly Reduced COPD Exacerbations in Second Positive Phase 3 Trial, Accelerating FDA Submission and Confirming Potential to Become First Approved Biologic for This Serious Disease
Published:
2023-11-27
(Crawled : 07:00)
- globenewswire.com
SNY
|
$46.72
-0.06%
-0.06%
1.1M
|
Health Technology
|
-1.25%
|
O:
1.04%
H:
0.17%
C:
0.11%
REGN
|
$814.86
-1.09%
0.31%
560K
|
Health Technology
|
3.06%
|
O:
-0.03%
H:
0.37%
C:
-0.49%
dupixent
fda
disease
approved
positive
copd
potential
submission
Press Release: Dupixent® significantly reduced COPD exacerbations in second positive Phase 3 trial, accelerating FDA submission and confirming potential to become first approved biologic for this serious disease
Published:
2023-11-27
(Crawled : 07:00)
- globenewswire.com
SNY
|
$46.72
-0.06%
-0.06%
1.1M
|
Health Technology
|
-1.25%
|
O:
1.04%
H:
0.17%
C:
0.11%
REGN
|
$814.86
-1.09%
0.31%
560K
|
Health Technology
|
3.06%
|
O:
-0.03%
H:
0.37%
C:
-0.49%
dupixent
fda
disease
approved
positive
copd
potential
submission
Biotech Breakthrough
Published:
2023-11-26
(Crawled : 00:00)
- spacfeed.com
SNY
|
$46.72
-0.06%
-0.06%
1.1M
|
Health Technology
|
-1.25%
|
O:
1.04%
H:
0.17%
C:
0.11%
biotech
Rabies Vaccine Market to Reach $ 1903.17 million by 2032, exhibiting a CAGR of 4.7% from 2023 to 2032: Allied Market Research
Published:
2023-11-25
(Crawled : 08:20)
- prnewswire.com
SNY
|
$46.72
-0.06%
-0.06%
1.1M
|
Health Technology
|
Email alert
Add to watchlist
ELAN
|
$12.4
5.26%
0.08%
6.6M
|
Process Industries
|
Email alert
Add to watchlist
SNYNF
|
$94.0
1.34%
1.34%
860
|
Health Technology
|
Email alert
Add to watchlist
NVS
|
$98.13
0.24%
-0.16%
1.2M
|
Health Technology
|
Email alert
Add to watchlist
NVSEF
|
$97.95
1.48%
2.98%
100
|
Health Technology
|
Email alert
Add to watchlist
ZTS
|
$179.13
1.39%
0.49%
1.4M
|
Health Technology
|
Email alert
Add to watchlist
FNCTF
|
$12.36
0.08%
-26.03%
1K
|
Communications
|
Email alert
Add to watchlist
vaccine
reach
research
market
← Previous
1
2
3
4
5
6
7
8
9
…
199
200
Next →
Gainers vs Losers
77%
23%
Top 10 Gainers
ID
4
|
$0.077
-9.41%
25.97%
420K
|
Finance
BKKT
4
|
$1.88
25.33%
14.89%
4.8M
|
MGLD
|
$1.03
7.77%
14K
|
Manufacturing
CZOO
|
$0.4316
-6.52%
6.7%
65K
|
SATX
|
$0.4226
-1.72%
6.48%
29K
|
n/a
CCJ
|
$45.4
-1.13%
4.6%
3.9M
|
Non-Energy Minerals
AUMN
|
$0.562
0.34%
4.5%
360K
|
Non-Energy Minerals
JBL
|
$116.91
1.38%
4.3%
2M
|
Electronic Technology
SAIC
4
|
$119.92
2.14%
4.24%
460K
|
Technology Services
CULP
4
|
$5.06
-0.59%
3.95%
29K
|
Process Industries
Your saved searches
Save your searches and get alerts when important news are released.